Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the BioTech industry. This time, you get to discover 5 hand-picked startups developing multiomics solutions.
Global Startup Heat Map highlights 5 Top Multiomics Solutions out of 133
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence-powered StartUs Insights Discovery Platform, covering 2.093.000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 133 exemplary startups & scaleups we analyzed for this research. Further, it highlights 5 BioTech startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these 5 startups & scaleups in this report. For insights on the other 128 multiomics solutions, get in touch.
Click to download
AgenT creates Blood Diagnostics
Blood-based diagnostics generally operate with threshold values. They yield a positive result if the levels of certain biomarkers are above a threshold. However, this is not useful for progressive diseases such as Alzheimer’s. Multiomics-based diagnostics integrate multiple layers of information to increase the sensitivity of diagnostics.
French startup AgenT provides blood diagnostics solutions. The startup’s multiomics platform utilizes Artificial Intelligence (AI) to identify biomarkers linked with different stages of Alzheimer’s. It combines information on proteins and metabolites to improve the sensitivity and specificity of diagnosis. By enabling early detection of the onset of Alzheimer’s, the startup’s solution helps clinicians optimize precision therapies.
OmniTier offers Tertiary Analysis
Due to developments in omics technologies, BioTech companies now possess large amounts of data at hand. Biological data analysis is critical to leveraging this data for applications across sectors. Tertiary analysis converts primary and secondary data into biological insights. Moreover, it allows companies to put biological variation in the context of populations.
OmniTier is a US-based startup that offers tertiary analysis for clinical, pharma, and research organizations. It utilizes a distributed, tiered memory-based technology to enable high-performance computing. CompStor Insight, the startup’s solution, allows researchers and clinicians to run next-generation sequencing (NGS) results. The multiomics platform supports custom omics workflows and databases and visualizes the results in an intuitive user interface.
Fauna Bio develops Translational Therapeutics
The unprecedented ability to generate large amounts of biological information, and interpret it, is driving innovation in the BioTech industry. With advances in different omics technologies, BioTech startups are now bringing them together to advance translational diagnostics and therapeutics. For instance, while tackling the COVID-19 pandemic, multiomics approaches have been crucial in understanding how the virus works.
Fauna Bio is a US-based startup identifying novel translational therapeutics in animal genomes. The startup’s multiomics drug discovery platform integrates data from multiple proprietary sources to identify novel drug targets. The startup focuses on genetic, epigenetic, and proteomic data from hibernating animals. Since these animals survive in extreme temperatures without food for long periods, Fauna Bio uses their data to derive insights on physiologically protective mechanisms.
Govita Tech enables Preventive Health
The genome and metabolome possess hints about an individual’s risk to particular diseases. Genomics and other omics technologies allow predicting the risk of disease onset. This enables a new paradigm in the form of preventive health. By combining insights from different omics technologies, startups personalize preventive health interventions to each patient.
Chinese startup Govita Tech develops molecular biomarker panels for preventive health applications. The startup combines genomics, metabolomics, and bioinformatics to interpret phenotype from genotype, predicting disease risk. It then recommends interventions and health plans that reduce the risk of disease onset. The startup’s solutions integrate multiomics and clinical phenotyping to provide insights into health and aging.
My Intelligent Machines (MIM) provides Biological Systems Modeling
A better understanding of biological systems is critical to further advances in the BioTech industry. However, biological systems are incredibly complex. This is why any single omics technology is often unable to provide valuable insights on disease progression, metabolic output, or any other function. Multiomics solutions integrate different kinds of biological information to model biological systems and derive valuable insights.
Canadian startup My Intelligent Machines leverages AI and big data to help BioTech companies maximize production. The startup’s platform, MIMsOmic, combines systems biology, bioinformatics, and machine learning to model biological systems across scales. With patient modeling, it enables patient stratification and target discovery. For agriculture applications, it facilitates breed stratification and genetic optimization.
Discover more BioTech Startups
BioTech startups such as the examples highlighted in this report focus on artificial intelligence, gene sequencing, tissue engineering as well as biomanufacturing. While all of these technologies play a major role in advancing the BioTech industry, they only represent the tip of the iceberg. To explore more technologies, simply get in touch to let us look into your areas of interest. For a more general overview, you can download our free BioTech Innovation Report to save your time and improve strategic decision-making.
